Abstract: A system for analyzing data from motion capture measurements has a sensor to measure motion capture measurements, a module configured to receive sensor data from the sensors, and a processor configured to analyze to the sensor data received from the sensors and create a report of such analysis. A computer-implemented method of analyzing data from motion capture measurements includes performing motion capture measurements on a subject, receiving motion capture data from the motion capture measurements, processing the motion capture data and the background data on a computer using an algorithm, including comparing the motion capture data and background data to one or more comparator waveforms, generating a report based on the processing analysis, and communicating the results of the report.

Abstract: An apparatus is disclosed that includes a switchable optical filter having a layer of switchable material; a light source providing light of a wavelength that causes the switchable material to transition from a faded state to a dark state, or a dark state to a faded state; and a switch for controlling activation of the light source.

Abstract: A front-end structure for a motor vehicle with electric front-wheel drive. The front-end structure includes at least two longitudinal members, at least one support unit, and at least one electric traction motor. The longitudinal members extending in a vehicle longitudinal direction and arranged at a lateral distance from each other. The support unit is fastened to the longitudinal members. The electric traction motor is fastened to a front-side crossmember that extends in a vehicle transverse direction and is fastened to the longitudinal members. The electric traction motor has at least one rear-side fastening section, which the electric traction motor is fastened to the support unit at the rear. The support unit has at least one section arranged to be offset relative to the rear-side fastening section.

Abstract: Methods and systems for embedding natural language sentences within a highly-dimensional vector space are provided. Additionally, various applications relating to natural language processing, are provided. Such applications include digital assistants and search engines, as well as systems for classifying, sorting, organizing, and/or pairing content that are associated with natural language objects. The sentence vector embeddings encode various semantic features of the sentence. Two separate language models, arranged in a serial architecture are employed to generate a sentence vector. The first language model generates token vectors for each of the tokens included in the sentence. The token vectors are employed as inputs to the second language model. The second language model generates the sentence vector for the sentence. A sentence vector embeds the semantic context of the corresponding natural language object within the vector space.

Abstract: The disclosure provides compositions, kits, and methods for detecting a plurality of genes and associated variants in a sample from a subject with cancer (e.g., lung cancer). The compositions, kits, and methods include a set of oligonucleotides, typically primers and/or probes that can hybridize to identify a gene variant. The methods disclosed herein provide for a mutation status of a tumor to be determined and subsequently associated with a report comprising an actionable treatment recommendation (e.g., a report comprising an actionable treatment recommendation).

Abstract: Systems, methods, and computer program products which facilitate the ability of a user to monitor and assess the location of and forces transferred to various joints, muscles, and limbs and their relative positions at each and every moment during normal daily activities, training loads of an exercise, or a competitive or high intensity athletic endeavors, in order to mitigate and reduce the risk of injury as well as to track fitness performance elements are disclosed. In an aspect, systems, methods, and computer program products are disclosed which utilize at least one sensor in order to capture a user's movement information during various tasks and exercises. This movement information may then be analyzed in order to determine quantifiable values for the user's likelihood of experiencing an injury and/or the user's overall fitness, generally.

Abstract: An apparatus and method for ensuring the accuracy and utility of cut-to-length systems. Multiple channels of measurement are employed, by which a first channel of measurement produces a first measurement of a work piece taken between a cutting mechanism and a limit stopper. A second channel of measurement produces a second measurement, wherein cutting of the work piece by the cutting mechanism cannot be made unless the first measurement agrees with the second measurement.

Abstract: The present invention provides a method for treating a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis with a pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier, comprising the steps of: (i) determining a genotype of the subject at a location corresponding to the location of one or more single nucleotide polymorphisms (SNPs) selected from the group consisting of: Group 1, (ii) identifying the subject as a predicted responder to glatiramer acetate if the genotype of the subject contains one or more A alleles at the location of Group 2, one or more C alleles at the location of Group 3, one or more G alleles at the location of Group 4, or one or more T alleles at the location of kgp18432055, kgp279772, kgp3991733 or kgp7242489; and (iii) administering the pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier to the subject only if the subject is identif

Abstract: The present invention provides a method for treating a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis with a pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier, comprising the steps of: (i) determining a genotype of the subject at a location corresponding to the location of one or more single nucleotide polymorphisms (SNPs) selected from the group consisting of: Group 1, (ii) identifying the subject as a predicted responder to glatiramer acetate if the genotype of the subject contains one or more A alleles at the location of Group 2, one or more C alleles at the location of Group 3, one or more G alleles at the location of Group 4, or one or more T alleles at the location of kgp18432055, kgp279772, kgp3991733 or kgp7242489; and (iii) administering the pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier to the subject only if the subject is identif

Abstract: The present invention relates to tools with wrenches and sockets recessed into the sides of the tool handles. The handles can be of any shape and applicable to any tool that uses a handle. Each side of a handle can contain a socket or wrench of different size so that one tool can include a complete set of sockets or wrenches.

Abstract: Systems, methods, and computer program products which facilitate the ability of a user to monitor and assess the location of and forces transferred to various joints, muscles, and limbs and their relative positions at each and every moment during normal daily activities, training loads of an exercise, or a competitive or high intensity athletic endeavors, in order to mitigate and reduce the risk of injury as well as to track fitness performance elements are disclosed. In an aspect, systems, methods, and computer program products are disclosed which utilize at least one sensor in order to capture a user's movement information during various tasks and exercises. This movement information may then be analyzed in order to determine quantifiable values for the user's likelihood of experiencing an injury and/or the user's overall fitness, generally.

Abstract: The present invention provides a method for treating a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis with a pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier, comprising the steps of: (i) determining a genotype of the subject at a location corresponding to the location of one or more single nucleotide polymorphisms (SNPs) selected from the group consisting of: rs1894408, kgp7747883, kgp6599438, rs10162089, rs16886004, kgp8110667, kgp8817856, kgp24415534, kgp6214351 and rs759458, (ii) identifying the subject as a predicted responder to glatiramer acetate if the genotype of the subject contains one or more A alleles at the location of kgp8110667, rs10162089, rs759458 and kgp6214351, or one or more G alleles at the location of kgp24415534, kgp6599438, kgp7747883, kgp8817856, rs16886004 and rs1894408; and (iii) administering the pharmaceutical composition comprising glatiramer acetate and a pharma

Abstract: The disclosure provides compositions, kits, and methods for detecting a plurality of genes and associated variants in a sample from a subject with lung cancer. The compositions, kits, and methods include a set of oligonucleotides, typically primers and/or probes that can hybridize to identify a gene variant. The methods disclosed herein provide for a mutation status of a tumor to be determined and subsequently associated with an actionable treatment recommendation.

Abstract: A switchable engine mount is provided. The switchable engine mount includes an end plate including one or more openings in fluidic communication with a hydraulic source and a channel plate coupled to the end plate and including one or more hydraulic flow openings. The switchable engine mount further includes a decoupler including at least one decoupler plate at least partially enclosed by the channel plate and the end plate and a switching plate positioned adjacent to the decoupler and configured to axially actuate the decoupler in response to reception of an input force from an actuator, the input force non-parallel to the axially actuation.

Abstract: A deployable hanger for a vehicle comprises a handle operable between deploying and non-deploying positions, two extension members disposed at least partially within the handle and tab members that are free of engagement with the extension members when the handle is in the deploying position, wherein the extension members are oppositely biased toward an extended position, and wherein the tab members selectively engage the extension members when the handle is in the non-deploying position.

Abstract: A deployable hanger for a vehicle comprises a handle operable between deploying and non-deploying positions, two extension members disposed at least partially within the handle and tab members that are free of engagement with the extension members when the handle is in the deploying position, wherein the extension members are oppositely biased toward an extended position, and wherein the tab members selectively engage the extension members when the handle is in the non-deploying position.

Abstract: The present invention relates to compositions for the control of pests, in particular insecticidal suspension concentrates and spray solutions made from them, to processes for their preparation, and to the use of such formulations for the sustained control of animal pests (arthropods) on a variety of surfaces. The present invention furthermore relates to the use of certain polymer dispersions in pesticides, in particular to their use for extending the long-term activity of these compositions when they are applied to surfaces. The present invention furthermore relates to the use of the compositions according to the invention for controlling parasites, in particular ectoparasites, in animals.

Abstract: The present invention provides a method for treating a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis with a pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier, comprising the steps of: (i) determining a genotype of the subject at a location corresponding to the location of one or more single nucleotide polymorphisms (SNPs) selected from the group consisting of: Group 1, (ii) identifying the subject as a predicted responder to glatiramer acetate if the genotype of the subject contains one or more A alleles at the location of Group 2, one or more C alleles at the location of Group 3, one or more G alleles at the location of Group 4, or one or more T alleles at the location of kgp18432055, kgp279772, kgp3991733 or kgp7242489; and (iii) administering the pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier to the subject only if the subject is identif

Abstract: A switchable engine mount is provided. The switchable engine mount includes an end plate including one or more openings in fluidic communication with a hydraulic source and a channel plate coupled to the end plate and including one or more hydraulic flow openings. The switchable engine mount further includes a decoupler including at least one decoupler plate at least partially enclosed by the channel plate and the end plate and a switching plate positioned adjacent to the decoupler and configured to axially actuate the decoupler in response to reception of an input force from an actuator, the input force non-parallel to the axially actuation.

Abstract: The present invention relates to compositions for the control of pests, in particular insecticidal suspension concentrates and spray solutions made from them, to processes for their preparation, and to the use of such formulations for the sustained control of animal pests (arthropods) on a variety of surfaces. The present invention furthermore relates to the use of certain polymer dispersions in pesticides, in particular to their use for extending the long-term activity of these compositions when they are applied to surfaces. The present invention furthermore relates to the use of the compositions according to the invention for controlling parasites, in particular ectoparasites, in animals.